Divisions of Baxter Novum and Renal Medicine,1 Karolinska Institutet, Stockholm, Sweden;
Perit Dial Int. 2013 Sep-Oct;33(5):487-94. doi: 10.3747/pdi.2012.00243. Epub 2013 Oct 1.
Although cardiovascular disease (CVD) is an important cause of morbidity and mortality in patients with end-stage renal disease, non-CVD causes account for more than 50% of total deaths. We previously showed that, compared with men, women starting dialysis-- both hemodialysis and peritoneal dialysis (PD)--have higher non-CVD mortality rates. Here, we evaluate sex-specific outcomes in a large cohort of incident PD patients.
Incident de novo PD patients from the Andalusian SICATA Registry for 1999 - 2010, with follow-up until 31 December 2010 or up to 5 years, were investigated for fatal outcomes. Causes of death were extracted from medical records. The analysis used traditional and competing-risk Cox models for all-cause and cause-specific mortality in men and women, correcting in the competing-risk models for the events of kidney transplantation and transfer to hemodialysis.
A total of 1458 patients (57% men; mean overall age: 55.3 ± 17.0 years) initiated PD in Andalusia during the study period. During follow-up, 350 deaths, 355 renal transplantation procedures, and 331 transfers to hemodialysis were recorded. Vascular disease and diabetic nephropathy were the most frequent causes of kidney failure in men; other causes were more common in women. In the traditional Cox model, both sexes showed a similar all-cause mortality risk [crude hazard ratio (HR): 0.90; 95% confidence interval (CI): 0.72 to 1.12]. However, with respect to specific causes of death, women showed a borderline lower risk of both CVD (crude HR: 0.71; 95% CI: 0.50 to 0.99) and non-CVD mortality from other than infection (crude HR: 0.81; 95% CI: 0.57 to 1.15). In contrast, the risk of death from infection was almost doubled in women compared with men (crude HR: 1.92; 95% CI: 1.15 to 3.20), a finding that held true after multivariate adjustment for age, primary renal disease, period of inclusion, and initial PD modality (adjusted HR: 1.76; 95% CI: 1.03 to 3.01). This result was confirmed even taking into consideration the competing events of kidney transplantation and transfer to hemodialysis.
Compared with men starting PD, women starting PD are at higher risk of mortality from infection. More stringent screening measures and corrective efforts in women might be indicated.
尽管心血管疾病(CVD)是终末期肾病患者发病率和死亡率的重要原因,但非 CVD 原因占总死亡人数的 50%以上。我们之前的研究表明,与男性相比,开始透析的女性(血液透析和腹膜透析[PD])的非 CVD 死亡率更高。在此,我们评估了大量新 PD 患者队列中的性别特异性结局。
我们对 1999 年至 2010 年期间安达卢西亚 SICATA 登记处的新发 PD 患者进行了研究,随访至 2010 年 12 月 31 日或最长 5 年,调查了致命结局。从病历中提取死因。分析采用传统和竞争风险 Cox 模型评估男性和女性的全因和病因特异性死亡率,并在竞争风险模型中校正了肾移植和转为血液透析的事件。
在研究期间,安达卢西亚共有 1458 名患者(57%为男性;平均总年龄:55.3±17.0 岁)开始 PD。随访期间,记录了 350 例死亡、355 例肾移植和 331 例转为血液透析。血管疾病和糖尿病肾病是男性肾衰竭的最常见原因;其他原因在女性中更为常见。在传统 Cox 模型中,两性的全因死亡率风险相似[粗危险比(HR):0.90;95%置信区间(CI):0.72 至 1.12]。然而,就特定死因而言,女性的 CVD(粗 HR:0.71;95%CI:0.50 至 0.99)和非感染性非 CVD 死亡率(粗 HR:0.81;95%CI:0.57 至 1.15)的风险呈边缘性降低。相比之下,与男性相比,女性因感染而死亡的风险几乎增加了一倍(粗 HR:1.92;95%CI:1.15 至 3.20),这种情况在考虑年龄、主要肾脏疾病、纳入期和初始 PD 方式的多变量调整后仍然存在(调整 HR:1.76;95%CI:1.03 至 3.01)。即使考虑到肾移植和转为血液透析的竞争事件,这一结果仍然成立。
与开始 PD 的男性相比,开始 PD 的女性感染死亡率更高。可能需要对女性进行更严格的筛查措施和纠正措施。